Super-enhancer analysis defines IRF4 as a target in anaplastic large cell lymphoma and rational design of IRF4 degrader molecules

被引：0
|
作者：
Giordano, C. [1 ]
Prutsch, N. [2 ]
Gurnhofer, E. [1 ]
Aplenc, A. [1 ]
Kenner, L. [1 ,3 ]
Look, A. T. [2 ]
Touaibia, M. [4 ]
Merkel, O. [1 ]
机构：
[1] Med Univ Vienna, Dept Pathol, Vienna, Austria
[2] Boston Childrens Hosp, Dept Pediat, Dana Farber Canc Inst, Boston, MA USA
[3] Univ Vet Med Vienna, Unit Lab Anim Pathol, Vienna, Austria
[4] Univ Moncton, Dept Chem & Biochem, Moncton, NB, Canada
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V871
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [1] Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
    Weilemann, Andre
    Grau, Michael
    Erdmann, Tabea
    Merkel, Olaf
    Sobhiafshar, Ulduz
    Anagnostopoulos, Ioannis
    Hummel, Michael
    Siegert, Antje
    Hayford, Claudia
    Madle, Hannelore
    Wollert-Wulf, Brigitte
    Fichtner, Iduna
    Doerken, Bernd
    Dirnhofer, Stephan
    Mathas, Stephan
    Janz, Martin
    Emre, N. C. Tolga
    Rosenwald, Andreas
    Ott, German
    Lenz, Peter
    Tzankov, Alexandar
    Lenz, Georg
    BLOOD, 2015, 125 (01) : 124 - 132
  • [2] LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT
    Plastinina, L., V
    Moiseeva, T. N.
    Al-Radi, L. S.
    Kovrigina, A. M.
    Obukhova, T. N.
    Goryacheva, S. R.
    Shupletsova, I. A.
    Magomedova, A. U.
    Kravchenko, S. K.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 445 - 457
  • [3] Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth
    Sakamoto, Hikaru
    Ando, Koji
    Imaizumi, Yoshitaka
    Mishima, Hiroyuki
    Kinoshita, Akira
    Kobayashi, Yuji
    Kitanosono, Hideaki
    Kato, Takeharu
    Sawayama, Yasushi
    Sato, Shinya
    Hata, Tomoko
    Nakashima, Masahiro
    Yoshiura, Koh-Ichiro
    Miyazaki, Yasushi
    CANCER SCIENCE, 2022, 113 (12) : 4092 - 4103
  • [4] IRF4 Expression without IRF4 Rearrangement Is a General Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
    Pham-Ledard, Anne
    Prochazkova-Carlotti, Martina
    Vergier, Beatrice
    Petrella, Tony
    Grange, Florent
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (05) : 1470 - 1472
  • [5] Large B-Cell Lymphoma With IRF4 Rearrangement Involving Lung
    Li, C.
    Teruya, B.
    Bhavana, D.
    Althof, P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S152 - S153
  • [6] Disruption of IRF4 in pediatric diffuse large B-cell lymphoma
    Sanmann, Jennifer N.
    Iqbal, Javeed
    Althof, Pamela A.
    Livermore, Chestnut A.
    Siebert, Reiner
    Sanger, Warren G.
    Chan, Wing C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 59 - 59
  • [7] Early pattern of large B-cell lymphoma with IRF4 rearrangement
    Granai, Massimo
    Lazzi, Stefano
    BLOOD, 2020, 136 (06) : 769 - 769
  • [8] Clinical boundaries in adult cases of large B cell lymphoma with IRF4 rearrangement
    Maguire, Jessica
    Harvey, Harry
    Jones, Alfred
    Law, Ruth
    Bashir, Masoud
    O'Brien, Odharnaith
    Sargent, Jeremy
    Grant, Cliona
    Flavin, Richard
    HISTOPATHOLOGY, 2024, 84 (02) : 399 - 401
  • [9] Gastrointestinal large B-cell lymphoma with IRF4 rearrangement - a case report
    Hurdogan, O.
    Yegen, G.
    Arslantas, E.
    Gulluoglu, M.
    Dogan, I. O.
    VIRCHOWS ARCHIV, 2018, 473 : S273 - S274
  • [10] IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas
    Bandini, Cecilia
    Pupuleku, Aldi
    Spaccarotella, Elisa
    Pellegrino, Elisa
    Wang, Rui
    Vitale, Nicoletta
    Duval, Carlotta
    Cantarella, Daniela
    Rinaldi, Andrea
    Provero, Paolo
    Di Cunto, Ferdinando
    Medico, Enzo
    Bertoni, Francesco
    Inghirami, Giorgio
    Piva, Roberto
    CANCERS, 2018, 10 (01):
12345